Seikagaku says JAMA Surgery publishes Japan trial results for SI-449 cs barrier adhesion device

• Seikagaku reported publication of Japan clinical trial results for its SI-449 adhesion barrier, marketed as cs barrierⓇ.
• Results were already presented via an article published in JAMA Surgery on Aug. 26, 2026.
• Study supported efficacy in open rectal resection, with safety outcomes consistent with use as a surgical adhesion barrier.
• Publication may strengthen clinical adoption prospects, supporting commercialization strategy for the product in surgical settings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seikagaku Corporation published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.